🔎 Trials Near Me

Akèy › Limfòm selil B › New Jersey › Edison

Etid klinik pou Limfòm selil B nan Edison, NJ

6 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Ap rekriteFaz 1/2
  • Research Site, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06564038

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Ap rekriteFaz 1
  • Clinical Trial Site, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06393738

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

Ap rekriteFaz 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT04792502

SynKIR-310 for Relapsed/Refractory B-NHL

Ap rekriteFaz 1
  • Rutgers Cancer Institute, New Brunswick · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1/2
  • Rutgers Cancer Institute of New Jersey (CINJ) - New Brunswick, New Brunswick · 3 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 24, 2025 · NCT05607420

Etid Limfòm selil B nan lòt vil

Lòt etid nan Edison

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.